NEW YORK (AP) — NEW YORK (AP) — Syndax Pharmaceuticals Inc. (SNDX) on Monday reported a loss of $49.4 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of 55 cents.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share.

The biopharmaceutical company posted revenue of $83.3 million in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $81.1 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX